Related Experiment Video
Updated: Jan 15, 2026
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
A retrospective study on clozapine-induced blood dyscrasias in the first 20 weeks of therapy
Mohsin Ali1, Ali Ahsan Mufti2, Abdur Razaq3
1Laboratory of Pharmaceutical Biotechnology, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium.
Objective:
Clozapine (CZP) is not commonly prescribed mainly because of the risk of serious adverse effects, particularly neutropenia. It can also cause blood disorders, ranging from mild to severe, affecting different blood cell types. The aim of this study was to investigate the incidence of hematological abnormalities in a Pakistani cohort of patients treated with antipsychotics using a comprehensive hematological monitoring program.
Methods:
The study included 288 patients categorized into three clinical groups based on antipsychotic treatment: Group TA (typical antipsychotics), Group AA (atypical antipsychotics), and Group CZP. During the initial 20-week treatment period, patients were regularly monitored hematological to assess changes in their blood profiles. The occurrence of various hematological abnormalities was investigated and analyzed using statistical models.
Results:
Blood dyscrasias were observed more frequently in patients in the CZP group than in the other groups. Specifically, neutropenia was seen in a few patients in group CZP. Notably, a positive clinical response to CZP treatment was significantly correlated with transient leukocytosis, transient neutrophilia, and persistent anemia. In contrast, poor clinical response to CZP medication was associated with transient leukopenia.
Conclusion:
CZP treatment resulted in more blood disorders than TA or AA treatments. While blood abnormalities were common with CZP, severe neutropenia was rare. Certain blood changes were linked to better treatment outcomes. Therefore, regular blood monitoring is recommended to optimize treatment effectiveness and manage side effects.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
08:38Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Psychosis: Goals of Pharmacotherapy
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...